You can buy or sell ATRA and other stocks, options, and ETFs commission-free!
Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. The listed name for ATRA is Atara Biotherapeutics, Inc. Common Stock.
South San Francisco, California
52 Week High
52 Week Low
-$0.74 per share
Available Mar 1, After Hours